For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Weill Cornell Medicine Multiple Sclerosis Center

You are here

News & Updates

Important Information about patient visits to the MS Center in light of COVID 19 Risk

Important Information about patient visits to the MS Center in light of COVID 19 Risk

Update on the coronavirus SARS-CoV-2 and the respiratory illness COVID 19: Incubation period and rationale for 14 days of Quarantine 
Recommendations about Coronavirus for our patients

Recommendations about Coronavirus for our patients

To our Multiple Sclerosis patients, their families and caregivers.The Coronavirus/COVID-19 outbreak is rapidly evolving, has entered the United States and willcertainly escalate before it subsides. The best up to date information can be obtained from theCenters for Disease Control at: https://www.cdc.gov/coronavirus/2019-ncov/about/index.htmlThe information in this posting is based on our best understanding of COVID-19 as of 3/4/2020.It is important to recognize that people with MS who are on...
Immune Disease Activity in MS may differ according to Ethnicity

Immune Disease Activity in MS may differ according to Ethnicity

People with MS self-identifying with the Black African diaspora, and/or with Latin American ethnicity are on average more likely to experience a severe MS disease course. This trend is supported by several independent studies conducted over the past two decades. Collectively, these studies show that clinical disability and MRI measures; including, lesion number, lesion volume, and tissue atrophy, tend to be significantly pronounced among study participants with MS self-reporting as African...

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021